Humana Inc. (HUM)

Market Cap	35.90B
Revenue (ttm)	115.01B
Net Income (ttm)	1.36B
Shares Out	120.41M
EPS (ttm)	11.19
PE Ratio	26.63
Forward PE	18.59
Dividend	$3.54 (1.19%)
Ex-Dividend Date	Dec 31, 2024

Volume	1,206,548
Open	296.00
Previous Close	295.71
Day's Range	295.41 - 303.03
52-Week Range	213.31 - 527.18
Beta	0.52
Analysts	Hold
Price Target	306.48 (+2.81%)
Earnings Date	Oct 30, 2024

About HUM

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provid...

• Industry: Healthcare Plans
• Sector: Healthcare
• IPO Date: Jan 22, 1993
• Employees: 67,600
• Stock Exchange: NYSE
• Ticker Symbol: HUM
• Website: https://www.humana.com

Financial Performance

In 2023, Humana's revenue was $106.37 billion, an increase of 14.54% compared to the previous year's $92.87 billion. Earnings were $2.49 billion, a decrease of -11.30%.

Analyst Forecast

According to 24 analysts, the average rating for HUM stock is "Hold." The 12-month stock price forecast is $306.48, which is an increase of 2.81% from the latest price.

Price Target

$306.48

(2.81% upside)

Analyst Consensus: Hold